An announcement from ENDRA Life Sciences ( ($NDRA) ) is now available. On October 29, 2025, ENDRA Life Sciences Inc. entered into an At-The-Market ...

The average one-year price target for ENDRA Life Sciences (NasdaqCM:NDRA) has been revised to $38.76 / share. This is a decrease of 17.39% from the prior estimate of $46.92 dated September 27, 2025.

Get key takeaways from Delcath Systems’ Q3 2025 earnings, clinical trial progress, and updated revenue outlook.